What Happened?
Newport Beach, CA-based jCyte Appointed Peter Kuper as Senior Vice President of Finance
About the Company
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company`s allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
About the Person
Peter Kuper is Senior Vice President of Finance at jCyte. Previously, Peter held various senior HR leadership roles in the industry.
Info Source
News
Short Profile